NCT00003307View on ClinicalTrials.gov

Radiation Therapy Plus Amifostine in Treating Patients With Primary Prostate Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

March 31, 1998

Primary Completion Date

June 30, 2001

Study Completion Date

June 30, 2001

Conditions
Prostate CancerRadiation Toxicity
Interventions
DRUG

amifostine trihydrate

RADIATION

radiation therapy

Trial Locations (1)

85724

Arizona Cancer Center, Tucson

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

University of Arizona

OTHER

NCT00003307 - Radiation Therapy Plus Amifostine in Treating Patients With Primary Prostate Cancer | Biotech Hunter | Biotech Hunter